{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T13:49:01Z","timestamp":1785160141146,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.clindermatol.2005.02.001","type":"journal-article","created":{"date-parts":[[2005,5,15]],"date-time":"2005-05-15T11:13:40Z","timestamp":1116155620000},"page":"311-314","source":"Crossref","is-referenced-by-count":55,"title":["Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification"],"prefix":"10.1016","volume":"23","author":[{"given":"Ronni","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit","family":"Matz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batsheva","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Orion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2005.02.001_bib1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/archderm.132.11.1315","article-title":"Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities","volume":"132","author":"Callot","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib3","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1172\/JCI113798","article-title":"Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk","volume":"82","author":"Shear","year":"1988","journal-title":"J Clin Invest"},{"issue":"Suppl 7","key":"10.1016\/j.clindermatol.2005.02.001_bib4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1528-1157.1998.tb01678.x","article-title":"Antiepileptic drug hypersensitivity syndrome","volume":"39","author":"Schlienger","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/00002018-199921060-00005","article-title":"Anticonvulsant hypersensitivity syndrome: incidence, prevention and management","volume":"21","author":"Knowles","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2165\/00128071-200304080-00006","article-title":"Differential diagnosis of severe cutaneous drug eruptions","volume":"4","author":"Bachot","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/ard.60.3.237","article-title":"Soluble CD95 concentrations are increased in patients with severe systemic lupus erythematosus, but not in their first degree relatives","volume":"60","author":"van der Linden","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib8","first-page":"535","article-title":"The phenytoin syndrome","volume":"32","author":"Tomsick","year":"1983","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/archderm.132.8.934","article-title":"Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature","volume":"132","author":"Knowles","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.clindermatol.2004.06.012","article-title":"Severe acute adverse cutaneous drug reactions","author":"Wolf","year":"2005","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1542\/peds.108.2.485","article-title":"Drug-induced hypersensitivity syndrome in pediatric patients","volume":"108","author":"Carroll","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib12","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib13","series-title":"Immunobiology","author":"Janeway","year":"2001"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-139-8-200310210-00012","article-title":"Delayed drug hypersensitivity reactions","volume":"139","author":"Pichler","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00130832-200410000-00013","article-title":"The immunological and clinical spectrum of delayed drug-induced exanthems","volume":"4","author":"Lerch","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1365-2222.2000.00847.x","article-title":"Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions","volume":"30","author":"Yawalkar","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib17","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1067\/mai.2000.110922","article-title":"Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions","volume":"106","author":"Yawalkar","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib18","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1046\/j.1365-2222.2001.01164.x","article-title":"T cell involvement in cutaneous drug eruptions","volume":"31","author":"Hari","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00130832-200108000-00004","article-title":"Immunohistology of drug-induced exanthema; clues to pathogenesis","volume":"1","author":"Yawalkar","year":"2001","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":"Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis","volume":"118","author":"Nassif","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01119.x","article-title":"Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors","volume":"119","author":"Le Cleach","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib23","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/00006534-200209010-00008","article-title":"Outcome of patients with toxic epidermal necrolysis syndrome revisited","volume":"110","author":"Ducic","year":"2002","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","article-title":"A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century","volume":"23","author":"Palmieri","year":"2002","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D397D8T291","article-title":"Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome","volume":"8","author":"Ghislain","year":"2002","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib26","first-page":"140","article-title":"Allopurinol hypersensitivity syndrome","volume":"27","author":"Lee","year":"1994","journal-title":"Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib27","first-page":"642","article-title":"Propylthiouracil-induced antineutrophil cytoplasm antibody-positive anaphylactoid purpura-like vasculitis \u2014 a case report","volume":"99","author":"Wang","year":"2000","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s100670050167","article-title":"Naproxen-induced leukocytoclastic vasculitis","volume":"19","author":"Schapira","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0732-8893(00)00238-8","article-title":"Cutaneous leucocytoclastic vasculitis associated with oxacillin","volume":"39","author":"Koutkia","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib30","first-page":"209","article-title":"Ciprofloxacin-induced vasculitis with cutaneous and renal involvement","volume":"21","author":"Pons","year":"2001","journal-title":"Nefrologia"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib31","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0140-6736(02)07922-9","article-title":"Fatal allergic vasculitis associated with celecoxib","volume":"359","author":"Schneider","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1345\/aph.1A124","article-title":"Cutaneous and systemic manifestations of drug-induced vasculitis","volume":"36","author":"ten Holder","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib33","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00007611-199905000-00010","article-title":"Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris","volume":"92","author":"Schrodt","year":"1999","journal-title":"South Med J"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib34","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1542\/peds.103.2.503","article-title":"Polyarteritis nodosa attributable to minocycline treatment for acne vulgaris","volume":"103","author":"Schrodt","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib35","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/rheumatology\/41.6.703","article-title":"Lethal medium-vessel panarteritis mimicking deep sepsis following etanercept and minocycline therapy in a patient with severe rheumatoid arthritis","volume":"41","author":"Berthelot","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/ard.55.10.769","article-title":"Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA","volume":"55","author":"Elkayam","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib37","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1046\/j.1365-4362.1999.00741.x","article-title":"Henoch-Schonlein purpura induced by clarithromycin","volume":"38","author":"Goldberg","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1507\/endocrj.49.315","article-title":"Acute pancreatitis, hepatic cholestasis, and erythema nodosum induced by carbimazole treatment for Graves' disease","volume":"49","author":"Marazuela","year":"2002","journal-title":"Endocr J"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00277-003-0790-2","article-title":"All-trans-retinoic acid\u2013induced erythema nodosum in patients with acute promyelocytic leukemia","volume":"83","author":"Kuo","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib40","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1046\/j.1365-4362.1998.00490.x","article-title":"Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia","volume":"37","author":"Kamaliah","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib41","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archderm.129.6.792","article-title":"Hyperamylasemia in toxic epidermal necrolysis","volume":"129","author":"Chosidow","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib42","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0190-9622(96)90297-2","article-title":"Renal involvement in toxic epidermal necrolysis","volume":"34","author":"Blum","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib43","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0190-9622(90)70333-D","article-title":"Toxic epidermal necrolysis (Lyell syndrome)","volume":"23","author":"Roujeau","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib44","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/0140-6736(91)90273-R","article-title":"Intestinal involvement in drug-induced toxic epidermal necrolysis","volume":"337","author":"Chosidow","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib45","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0736-4679(02)00684-4","article-title":"A fatal case of toxic epidermal necrolysis associated with liver cirrhosis","volume":"24","author":"Uzum","year":"2003","journal-title":"J Emerg Med"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/archinte.162.4.474","article-title":"Fulminant hepatitis and fatal toxic epidermal necrolysis (Lyell disease) coincident with clarithromycin administration in an alcoholic patient receiving disulfiram therapy","volume":"162","author":"Masia","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clindermatol.2005.02.001_bib47","first-page":"182","article-title":"Ischemic hepatitis associated with toxic epidermal necrolysis in a cirrhotic patient treated with cefuroxime","volume":"2","author":"Yossepowitch","year":"1997","journal-title":"Eur J Med Res"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X05000349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X05000349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T00:39:10Z","timestamp":1625963950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X05000349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0738081X05000349"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2005.02.001","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}